Virtual Reality Program for Managing Chronic Neck Pain
ConditionChronic Neck Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorHacettepe University
About this trial
The goal of this clinical trial is to find out if a virtual reality-based rehabilitation program developed by our team can help people with chronic neck pain.
The main questions it aims to answer are:
* Does the VR program reduce neck pain? * Does it improve daily function and quality of life?
Participants will:
* Take part in a supervised virtual reality exercise program for 8 weeks, attending 3 sessions per week (24 sessions in total). * Each session will last about 45 minutes. * Complete tests and questionnaires about their pain, disability, and overall well-being before and after the program.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-65 years
Diagnosis of chronic neck pain (≥ 6 months duration)
Ability to participate in rehabilitation sessions
Willingness to provide written informed consent
Disqualifiers
Previous adverse experience with virtual reality
Photophobia (UPSIS-12 score > 12)
Migraine (≥ 2 positive responses on ID-Migraine questionnaire)
Presence of any neurological deficit
Trial design
Design model
Parallel
Treatments tested in this trial
Virtual Reality Rehabilitation
Other interventionA virtual reality-based rehabilitation program including breathing, stretching, cervical range-of-motion, and posture-strengthening tasks delivered in a gamified seaside environment using a head-mounted VR display. Sessions will last 20 minutes, performed twice per week for 8 weeks (16 sessions total) under supervision.
Conventional Rehabilitation
Other interventionStandard physiotherapy including diaphragmatic breathing, trapezius stretching, cervical range-of-motion, and posture-strengthening with proprioceptive neuromuscular facilitation. Sessions will last 20 minutes, performed twice per week for 8 weeks (16 sessions total) under supervision.
Treatment groups
32 Participants
are divided into 2 treatment groupsGroup A: Virtual Reality Treatment GroupExperimental treatment 1 intervention
Group B: Conventional Therapy GroupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Pain Intensity
Pain severity will be measured using the Visual Analog Scale (VAS), a 10-cm line ranging from 0 (no pain) to 10 (worst imaginable pain), where participants indicate their average neck pain intensity over the past week. Higher scores represent greater pain (worse outcome).
Time frame
Baseline and at the end of the study.2
Neck Disability
Functional disability will be evaluated using the Neck Disability Index (NDI), a 10-item self-report questionnaire assessing daily activities affected by neck pain. Each item is scored from 0 to 5, yielding a total score range of 0 (no disability) to 50 (maximum disability). Higher scores indicate greater disability (worse outcome).
Time frame
Baseline and at the end of the study.3
Cervical Range of Motion
Cervical range of motion (flexion, extension, right/left lateral flexion, and right/left rotation) will be measured using the CROM device. Higher values indicate greater mobility.
Time frame
Baseline and at the end of the study.4
Proprioception
Proprioceptive accuracy will be assessed by measuring joint position sense error in degrees using the CROM device. Higher error values indicate poorer position sense.
Time frame
Baseline and at the end of the study.Secondary outcomes
1
Life Quality
Quality of life status will be measured using the Short Form-36 Health Survey (SF-36). Scores range from 0 (worst possible health status) to 100 (best possible health status). Higher scores indicate better health-related quality of life.
Time frame
Baseline and at the end of the study.2
Kinesiophobia
Fear of movement will be assessed using the Tampa Scale of Kinesiophobia (TSK), a 17-item self-report questionnaire. Each item is scored from 1 to 4, yielding a total score range of 17 (no kinesiophobia) to 68 (maximum kinesiophobia). Higher scores indicate more severe kinesiophobia (worse outcome).
Time frame
Baseline and at the end of the study.3
Treatment Adherence
Attendance at scheduled sessions will be recorded to determine adherence to the VR or conventional therapy program. Higher percentages reflect better adherence.
Time frame
At the end of the study.4
Participant Satisfication
Perceived overall change will be evaluated using the Global Perceived Effect (GPE) Scale, a 7-point Likert-type scale assessing the participant's impression of improvement following the treatment program. Scores range from 1 (much worse) to 7 (much better), with 4 indicating no change. Higher scores indicate greater perceived improvement (better outcome).
Time frame
At the end of the study.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: